|
|||||
|
|
Vildagliptin reduces plasma stromal cell‐derived factor‐1α in patients with type 2 diabetes compared with glimepiride |
|
| Authors: | Kyeong Seon Park SooHeon Kwak Young Min Cho Kyong Soo Park Hak C Jang Seong Yeon Kim Hye Seung Jung |
| Affiliation: | 1. Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea;2. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Gyeonggi‐do, Korea |
| Abstract: | |
| Keywords: | Cardiovascular risk Stromal cell‐derived factor‐1α Vildagliptin |